Table 2. Effects of endoplasmic reticulum stress inhibitor treatments during activation procedure on the in vitro development of parthenogenetic embryos
Treatment | No. of embryos cultured | No. of embryos developed to | Cell number (mean±S.E.) |
≥2-cell (%) | Blastocyst (%) |
E | Control | 295 | 203 (68.8) | 43 (14.2)a | 27.1±2.6a |
Sal | 290 | 215 (74.1) | 66 (22.8)b | 66.1±5.3b |
TUD | 287 | 207 (72.1) | 64 (22.3)b | 65.0±9.4b |
Sal+TUD | 289 | 221 (76.5) | 42 (14.5)a | 47.4±6.2b |
EC | Control | 305 | 204 (66.9) | 41 (13.4)a | 43.6±4.9a |
Sal | 300 | 224 (74.7) | 57 (19.0)ab | 74.4±2.8b |
TUD | 311 | 239 (76.8) | 67 (21.5)b | 63.9±8.2b |
Sal+TUD | 299 | 226 (75.6) | 52 (17.4)ab | 70.7±4.4b |
Values with different letters are significantly different (p<0.05).